According to Zhitong Finance App News, Toujing Life (300642.SZ) announced that the company's holding subsidiaries Jiangxi Toujing Life Technology Co., Ltd. (hereinafter referred to as “Jiangxi Toujing”) and Shanghai Maxi Biotechnology Co., Ltd. (hereinafter referred to as “Maxi Biotech”) have recently obtained medical device registration certificates issued by the Jiangxi Drug Administration and the Shanghai Drug Administration respectively. Products involved: “Fully automatic flow fluorescence immunoassay analyzer (model, specification: TESMIF5000, TESMIF5000M)”, “Four anti-seizure drug concentration determination kit (liquid chromatography tandem mass spectrometry)”.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.